Hirano T, Nakagawa A, Ohki T, Uenohara H, Takayama K, Tominaga T
1Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Minim Invasive Neurosurg. 2008 Dec;51(6):324-8. doi: 10.1055/s-0028-1085429. Epub 2008 Dec 5.
Mechanical removal of intravascular clots in addition to administration of tissue plasminogen activator are both desirable for improved outcome in acute embolic stroke. We have developed a novel endovascular catheter system for rapid and reliable mechanical recanalization of cerebral embolisms with little or no requirement for fibrinolytic agents. Here, we describe the evaluation of this device in vitro.
Pulsed liquid jets were generated and ejected from the catheter exit by accelerating cold physiological saline (4 degrees C, 40 mL/h) using the energy of a pulsed holmium:yttrium-aluminum-garnet (YAG) laser (3 Hz, 1.2 W). Accessibility beyond the tortuous cavernous portion of the internal carotid artery to the M1 and A1 regions was confirmed using a transparent model of the human cerebral artery. Mechanical characteristics of the liquid jets were evaluated with a high-speed camera. Liquid jets of physiological saline or urokinase solution (1,200 IU/mL) were exposed to artificial thrombi made of human blood under temperature monitoring. Remnants of thrombi were collected and incubated at 37 degrees C for 10 min for estimation of fibrinolysis rates.
The jet velocity (maximum: 5 m/s) was controlled by changing the laser energy. The fibrinolysis rates (mean+/-SD) after exposure to jets of saline or urokinase solution for 45 s were 62.2+/-16.4 and 94.0+/-3.4%, respectively, and were significantly better than the rate of 8.1+/-2.0% with administration of urokinase alone. The local temperature rise was less than 8 degrees C.
The results show that the laser-induced liquid jet catheter system may be a powerful tool for mechanical destruction of emboli and augmentation of the effect of fibrinolytic agents beyond the tortuous part of the internal carotid artery.
除了给予组织纤溶酶原激活剂外,机械清除血管内血栓对于改善急性栓塞性中风的预后均是可取的。我们开发了一种新型血管内导管系统,用于快速、可靠地机械再通脑栓塞,对纤维蛋白溶解剂的需求很少或几乎不需要。在此,我们描述该装置的体外评估。
通过使用脉冲钬:钇铝石榴石(YAG)激光(3Hz,1.2W)的能量加速冷生理盐水(4℃,40mL/h),从导管出口产生并喷射脉冲液体射流。使用人脑动脉透明模型确认了颈内动脉迂曲海绵状部分以外至M1和A1区域的可达性。用高速相机评估液体射流的机械特性。在温度监测下,将生理盐水或尿激酶溶液(1200IU/mL)的液体射流暴露于由人血制成的人工血栓。收集血栓残余物并在37℃孵育10分钟以估计纤维蛋白溶解率。
通过改变激光能量来控制射流速度(最大值:5m/s)。暴露于生理盐水或尿激酶溶液射流45秒后的纤维蛋白溶解率(平均值±标准差)分别为62.2±16.4%和94.0±3.4%,明显优于单独给予尿激酶时的8.1±2.0%。局部温度升高小于8℃。
结果表明,激光诱导液体射流导管系统可能是一种强大的工具,用于机械破坏栓子并增强纤维蛋白溶解剂在颈内动脉迂曲部分以外的作用。